Breaking News Instant updates and real-time market news.

RNGR

Ranger Energy

$6.80

-0.05 (-0.73%)

17:02
11/06/18
11/06
17:02
11/06/18
17:02

Ranger Energy reports Q3 EPS 23c, consensus 17c

Reports Q3 revenue $82.1M vs. $73.1M last year. Q3 Adjusted EBITDA increased 30% to $12.6M.

RNGR Ranger Energy
$6.80

-0.05 (-0.73%)

03/09/18
FBCO
03/09/18
DOWNGRADE
Target $8
FBCO
Neutral
Ranger Energy downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst James Wicklund downgraded Ranger Energy Services to Neutral and cut his price target for the shares to $8 from $11. The company "continues to struggle to meet its pre-IPO expectations," missing its second quarter since coming public, Wicklund tells investors in a research note. The analyst is concerned by the delay in Ranger meeting its financial goals.
03/12/18
WELS
03/12/18
DOWNGRADE
WELS
Market Perform
Ranger Energy downgraded to Market Perform from Outperform at Wells Fargo
03/12/18
WELS
03/12/18
DOWNGRADE
Target $9
WELS
Market Perform
Ranger Energy downgraded to Market Perform with $9 target at Wells Fargo
Wells Fargo analyst Judson Bailey downgraded Ranger Energy Services to Market Perform from Outperform and lowered his price target for the shares to $9 from $18. The analyst says the growth and margin improvement story he originally forecasted has come in "well below expectations along with disappointing free cash flow." Both the company's profitability and growth have disappointed meaningfully relative to expectations, Bailey tells investors in a research note. Further, he believes the macro backdrop in well service will remain competitive, making future margin improvements a challenge.
03/12/18
03/12/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ranger Energy (RNGR) downgraded to Market Perform from Outperform at Wells Fargo with analyst Judson Bailey saying the growth and margin improvement story he originally forecasted has come in "well below expectations along with disappointing free cash flow." 2. Voyager Therapeutics (VYGR) was downgraded to In Line from Outperform at Evercore ISI and to Neutral from Outperform at Wedbush. 3. HubSpot (HUBS) downgraded to In Line from Outperform at Evercore ISI with analyst Kirk Materne saying he is taking a "few chips off the table" and sees more balanced risk/reward at current levels. 4. XL Group (XL) downgraded to Market Perform from Outperform at JMP Securities with analyst Matthew Carletti saying that he sees low odds of a superior offer following the company's announcement of a deal to be acquired by AXA (AXAHY) for $57.60 per share in cash. 5. Blackbaud (BLKB) downgraded to Underperform from In Line at Evercore ISI with analyst Kirk Materne saying Blackbaud's valuation reflects the current cloud transition and lower tax rate and is full relative to the company's TTM organic growth rate. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

VBLT

VBL Therapeutics

$1.14

-0.04 (-3.39%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Hot Stocks
VBL Therapeutics reports results from GLOBE study at SNO »

VBL Therapeutics reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 27

    Nov

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

, QURE

uniQure

$31.00

8.21 (36.02%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Upgrade
Spark Therapeutics, uniQure rating change  »

Spark Therapeutics…

ONCE

Spark Therapeutics

$38.91

-2.02 (-4.94%)

QURE

uniQure

$31.00

8.21 (36.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APC

Anadarko

$55.49

1.09 (2.00%)

07:30
11/16/18
11/16
07:30
11/16/18
07:30
Recommendations
Anadarko analyst commentary  »

Anadarko strategic update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
Nvidia analyst commentary  »

Nvidia likely to remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

AXP

American Express

$109.52

1.75 (1.62%)

, COF

Capital One

$89.21

0.29 (0.33%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Recommendations
American Express, Capital One analyst commentary  »

American Express new top…

AXP

American Express

$109.52

1.75 (1.62%)

COF

Capital One

$89.21

0.29 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

BCRX

BioCryst

$7.31

0.31 (4.43%)

07:26
11/16/18
11/16
07:26
11/16/18
07:26
Hot Stocks
BioCryst presents BCX7353 data at ACAAI meeting »

BioCryst presented data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

UBSH

Union Bankshares

$34.26

0.455 (1.35%)

07:25
11/16/18
11/16
07:25
11/16/18
07:25
Recommendations
Union Bankshares analyst commentary  »

Union Bankshares deserves…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:24
11/16/18
11/16
07:24
11/16/18
07:24
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

TPR

Tapestry

$40.99

-0.11 (-0.27%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Recommendations
Tapestry analyst commentary  »

Tapestry price target cut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

IFF

International Flavors

$142.28

1.01 (0.71%)

07:23
11/16/18
11/16
07:23
11/16/18
07:23
Initiation
International Flavors initiated  »

International Flavors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLOG

GasLog

$20.02

0.17 (0.86%)

, GLOP

GasLog Partners

$24.01

0.16 (0.67%)

07:22
11/16/18
11/16
07:22
11/16/18
07:22
Hot Stocks
GasLog, GasLog Partners to modify IDR »

GasLog (GLOG) and GasLog…

GLOG

GasLog

$20.02

0.17 (0.86%)

GLOP

GasLog Partners

$24.01

0.16 (0.67%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KORS

Michael Kors

$47.22

-0.77 (-1.60%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Downgrade
Michael Kors rating change  »

Michael Kors downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$202.65

5.43 (2.75%)

07:21
11/16/18
11/16
07:21
11/16/18
07:21
Recommendations
Nvidia analyst commentary  »

Nvidia price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 10

    Dec

GAB

Gabelli Eqty Trust

$6.03

0.02 (0.33%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Hot Stocks
Gabelli backs 10% distribution policy, raises Q4 distribution to 19c per share »

The board of The Gabelli…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:20
11/16/18
11/16
07:20
11/16/18
07:20
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
FX Update: The dollar has traded mixed »

FX Update: The dollar has…

07:20
11/16/18
11/16
07:20
11/16/18
07:20
General news
Canada manufacturing preview »

Canada manufacturing…

AMAT

Applied Materials

$35.03

1.44 (4.29%)

07:19
11/16/18
11/16
07:19
11/16/18
07:19
Recommendations
Applied Materials analyst commentary  »

Citi adds Applied…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$52.33

-4.05 (-7.18%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Blueprint Medicines analyst commentary  »

Blueprint Medicines data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

CUB

Cubic

$65.71

1.78 (2.78%)

07:18
11/16/18
11/16
07:18
11/16/18
07:18
Recommendations
Cubic analyst commentary  »

Cubic well positioned for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.59

1.09 (1.72%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Periodicals
Citi says clients are adjusting supply chains due to trade war, CNBC reports »

Citi said their corporate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

SIGI

Selective Insurance

$64.11

1.81 (2.91%)

07:17
11/16/18
11/16
07:17
11/16/18
07:17
Initiation
Selective Insurance initiated  »

Selective Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

AGIO

Agios Pharmaceuticals

$67.26

3.54 (5.56%)

07:16
11/16/18
11/16
07:16
11/16/18
07:16
Hot Stocks
Agios Pharmaceuticals presents data from AG-881 study at SNO »

Agios Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

JCP

J.C. Penney

$1.37

0.14 (11.38%)

07:15
11/16/18
11/16
07:15
11/16/18
07:15
Downgrade
J.C. Penney rating change  »

J.C. Penney downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.